Navin Fluorine International Limited (NFIL) Latest Updates

Corporate and Financial Updates The company is scheduled to hold a Board Meeting on October 30, 2025, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ending September 30, 2025. The board will also consider the declaration of an Interim Dividend for the financial year 2025-2026. In earlier news, NFIL successfully raised ₹750 crore through a Qualified Institutional Placement (QIP) in July 2025. The company allocated over 16 lakh equity shares to qualified institutional buyers at ₹4,680 per share. The Q1 FY26 results (for the quarter ending June 30, 2025) reported a significant financial performance, with the consolidated net profit soaring by approximately 129% to ₹117.17 crore year-on-year, and revenue from operations increasing by about 38.5% to ₹725.40 crore. Capacity Expansion and New Facilities Navin Fluorine has recently inaugurated Phase-1 of its new cGMP-4 facility of Navin Molecular at its Dewas unit. This facility is part of a larger planned expenditure and is ready for commissioning, with validation batches already underway for a European partner, strengthening the company's Contract Development and Manufacturing Organisation (CDMO) services. The company also recently commenced commercial operations of its new hydrofluorocarbon (HFC) R32 production facility at its Surat plant. This project, which entailed an investment of ₹84 crore, adds 4,500 tonnes per annum to NFIL's existing R32 capacity.